Terms: = Skin cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
17 results:
1. Hesperetin activates CISD2 to attenuate senescence in human keratinocytes from an older person and rejuvenates naturally aged skin in mice.
Shen ZQ; Chang CY; Yeh CH; Lu CK; Hung HC; Wang TW; Wu KS; Tung CY; Tsai TF
J Biomed Sci; 2024 Jan; 31(1):15. PubMed ID: 38263133
[TBL] [Abstract] [Full Text] [Related]
2. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through foxo3a-ACSL4 axis-regulated ferroptosis.
Wang Q; Gao S; Shou Y; Jia Y; Wei Z; Liu Y; Shi J; Miao D; Miao Q; Zhao C; Liu C; Yang H; Xu T; Zhang X
Int J Biol Sci; 2023; 19(4):1266-1283. PubMed ID: 36923928
[TBL] [Abstract] [Full Text] [Related]
3. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/foxo3a signalling pathway.
Yan F; Liao R; Silva M; Li S; Jiang Y; Peng T; Lazarovici P; Zheng W
J Cell Mol Med; 2020 Jun; 24(11):6208-6219. PubMed ID: 32347651
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of mTORC2 enhances UVB-induced apoptosis in keratinocytes through a mechanism dependent on the foxo3a transcriptional target NOXA but independent of TRAIL.
Feehan RP; Nelson AM; Shantz LM
Cell Signal; 2018 Dec; 52():35-47. PubMed ID: 30172026
[TBL] [Abstract] [Full Text] [Related]
5. Elucidating the role of the foxo3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract] [Full Text] [Related]
6. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
[TBL] [Abstract] [Full Text] [Related]
7. Adenovirus-mediated fkhrl1/TM sensitizes melanoma cells to apoptosis induced by temozolomide.
Egger ME; McNally LR; Nitz J; McMasters KM; Gomez-Gutierrez JG
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):186-95. PubMed ID: 25238278
[TBL] [Abstract] [Full Text] [Related]
8. foxo3a is an antimelanogenic factor that mediates antioxidant-induced depigmentation.
Kim J; Choi H; Cho EG; Lee TR
J Invest Dermatol; 2014 May; 134(5):1378-1388. PubMed ID: 24284420
[TBL] [Abstract] [Full Text] [Related]
9. Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma.
Bosserhoff AK; Ellmann L; Quast AS; Eberle J; Boyle GM; Kuphal S
Mol Carcinog; 2014 Aug; 53(8):635-47. PubMed ID: 23625515
[TBL] [Abstract] [Full Text] [Related]
10. The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.
Touil Y; Zuliani T; Wolowczuk I; Kuranda K; Prochazkova J; Andrieux J; Le Roy H; Mortier L; Vandomme J; Jouy N; Masselot B; Ségard P; Quesnel B; Formstecher P; Polakowska R
Stem Cells; 2013 Apr; 31(4):641-51. PubMed ID: 23355370
[TBL] [Abstract] [Full Text] [Related]
11. Adenovirus-mediated expression of mutated forkhead human transcription like-1 suppresses tumor growth in a mouse melanoma xenograft model.
Gomez-Gutierrez JG; Egger ME; Hao H; Zhou HS; McMasters KM
Cancer Biol Ther; 2012 Oct; 13(12):1195-204. PubMed ID: 22892845
[TBL] [Abstract] [Full Text] [Related]
12. Pachastrissamine from Pachastrissa sp. inhibits melanoma cell growth by dual inhibition of Cdk2 and ERK-mediated foxo3 downregulation.
Yoo H; Lee YS; Lee S; Kim S; Kim TY
Phytother Res; 2012 Dec; 26(12):1927-33. PubMed ID: 22451302
[TBL] [Abstract] [Full Text] [Related]
13. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
Paraiso KH; Haarberg HE; Wood E; Rebecca VW; Chen YA; Xiang Y; Ribas A; Lo RS; Weber JS; Sondak VK; John JK; Sarnaik AA; Koomen JM; Smalley KS
Clin Cancer Res; 2012 May; 18(9):2502-14. PubMed ID: 22351686
[TBL] [Abstract] [Full Text] [Related]
14. PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.
Paraiso KH; Xiang Y; Rebecca VW; Abel EV; Chen YA; Munko AC; Wood E; Fedorenko IV; Sondak VK; Anderson AR; Ribas A; Palma MD; Nathanson KL; Koomen JM; Messina JL; Smalley KS
Cancer Res; 2011 Apr; 71(7):2750-60. PubMed ID: 21317224
[TBL] [Abstract] [Full Text] [Related]
15. Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?
Kamstrup MR; Biskup E; Gniadecki R
Br J Dermatol; 2010 Oct; 163(4):781-8. PubMed ID: 20560956
[TBL] [Abstract] [Full Text] [Related]
16. Activation of foxo3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
Yang JY; Chang CJ; Xia W; Wang Y; Wong KK; Engelman JA; Du Y; Andreeff M; Hortobagyi GN; Hung MC
Cancer Res; 2010 Jun; 70(11):4709-18. PubMed ID: 20484037
[TBL] [Abstract] [Full Text] [Related]
17. Adenovirus-mediated gene transfer of fkhrl1 triple mutant efficiently induces apoptosis in melanoma cells.
Gomez-Gutierrez JG; Souza V; Hao HY; Montes de Oca-Luna R; Dong YB; Zhou HS; McMasters KM
Cancer Biol Ther; 2006 Jul; 5(7):875-83. PubMed ID: 16861905
[TBL] [Abstract] [Full Text] [Related]
